Simeon George - 16 Jul 2025 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Reporting relationship: Director
Issuer ticker: CRSP
Reported as of: 16 Jul 2025
Net transaction value: +$51,499,918
SEC form: 4
Accepted by SEC: 17 Jul 2025, 17:19:13 UTC
Prior SEC filing: 12 Jun 2025
Next SEC filing: 09 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Sasha Keough, attorney-in-fact for Simeon George

Key filing fact

Simeon George filed Form 4 for CRISPR Therapeutics AG (CRSP) on 17 Jul 2025.

Key facts

This page summarizes Simeon George's Form 4 filing for CRISPR Therapeutics AG (CRSP).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 17 Jul 2025, 17:19.

Change

Previous filing in this sequence was filed on 12 Jun 2025.
Current net transaction value: +$51,499,918.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001595117 Primary reporting owner

George Simeon

Relationship: Director
Address: 985 OLD EAGLE SCHOOL ROAD SUITE 511, WAYNE
Signature: /s/ Sasha Keough, attorney-in-fact for Simeon George
Signature date: 17 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRSP transaction

Common Shares

Purchase

Transaction value: $338,715
Shares: +6,510
Change %: +10%
Price: $52.03
Shares after: 69,687
Date: 16 Jul 2025
Ownership: See Note 1
Footnotes: F1

CRSP transaction

Common Shares

Purchase

Transaction value: $1,161,258
Shares: +22,319
Change %: +10%
Price: $52.03
Shares after: 238,897
Date: 16 Jul 2025
Ownership: See Note 2
Footnotes: F2

CRSP transaction

Common Shares

Purchase

Transaction value: $49,999,945
Shares: +960,983
Change %: +125%
Price: $52.03
Shares after: 1,730,179
Date: 16 Jul 2025
Ownership: See Note 3
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The Reporting Person is the sole managing member of SR One Capital Management, LLC ("SR One Capital Management"), which is the sole general partner of SR One Capital Partners II, LP ("SR One Partners II"). SR One Partners II is the sole general partner of SR One Capital Fund II Aggregator, LP ("SR One Fund II Aggregator"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16"), or otherwise of such portion of the securities held by SR One Fund II Aggregator in which the Reporting Person has no pecuniary interest.

Footnote F2

The Reporting Person is the sole managing member of SR One Capital Management, which is the sole general partner of SR One Capital Opportunities Partners I, LP ("SR One Opportunities Partners I"). SR One Opportunities Partners I is the sole general partner of SR One Capital Opportunities Fund I, LP ("SR One Opportunities Fund I"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 or otherwise of such portion of the securities held by SR One Opportunities Fund I in which the Reporting Person has no pecuniary interest.

Footnote F3

The Reporting Person is the sole managing member of SR One Capital Management, which is the sole general partner of SR One Capital SMA Partners, LP ("SMA Partners"). SMA Partners is the sole general partner of AMZL, LP ("AMZL"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 or otherwise of such portion of the securities held by AMZL in which the Reporting Person has no pecuniary interest.